|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02018302 |
|
Date of registration:
|
11/12/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Post Study Continuation of C7 for G1D
|
|
Scientific title:
|
Post Study Continuation of C7 for G1D |
|
Date of first enrolment:
|
October 2013 |
|
Target sample size:
|
|
|
Recruitment status: |
No longer available |
|
URL:
|
https://clinicaltrials.gov/show/NCT02018302 |
|
Study type:
|
Expanded Access |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Juan M Pascual, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
UT Southwestern Medical Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients enrolled in the pilot trial (UTSW 122010-186)
Exclusion Criteria:
- Subjects who did not complete the pilot trial (UTSW 122010-186)
Age minimum:
1 Month
Age maximum:
28 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Glut1 Deficiency Syndrome
|
|
Glucose Transporter Type 1 Deficiency Syndrome
|
|
Intervention(s)
|
|
Drug: Triheptanoin
|
|
Secondary ID(s)
|
|
UTSW 082013-016
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|